Profil
Mats Hellstrom was the founder of AngioGenetics AB, where he held the title of Chief Executive Officer from 2001 to 2009.
AngioGenetics AB was founded in 2001.
Dr. Hellstrom earned a doctorate degree from the University of Gothenburg in 2000.
Anciens postes connus de Mats Hellstrom
| Sociétés | Poste | Fin |
|---|---|---|
AngioGenetics AB
 AngioGenetics AB Pharmaceuticals: GenericHealth Technology AngioGenetics AB develops, markets, and distributes generic drugs. It develops angiogenesis modulating drugs for the treatment of cancer, ischemic heart disease, and eye diseases. The company was founded in June 2001 and is headquartered in Göteborg, Sweden. | Fondateur | - |
Formation de Mats Hellstrom
| University of Gothenburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
AngioGenetics AB
AngioGenetics AB Pharmaceuticals: GenericHealth Technology AngioGenetics AB develops, markets, and distributes generic drugs. It develops angiogenesis modulating drugs for the treatment of cancer, ischemic heart disease, and eye diseases. The company was founded in June 2001 and is headquartered in Göteborg, Sweden. | Health Technology |
